Editorial: Study of adherence comes to the treatment of chronic hepatitis B

Journal of Hepatology

Volumn 54, Issue 1, 2011, Pages 6-8

  Lee, Maximilian ^a   Keeffe, Emmet B ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ANTIVIRUS AGENT; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ENTECAVIR; LAMIVUDINE; TELBIVUDINE; TENOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL THERAPY; DECOMPENSATED LIVER CIRRHOSIS; EDITORIAL; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEPATITIS B; HEPATITIS B VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; SOCIAL ASPECT; NOTE; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; STATISTICS;

ANTIVIRAL AGENTS; HEPATITIS B, CHRONIC; HUMANS; MEDICATION ADHERENCE; RETROSPECTIVE STUDIES;

EID: 78649636795     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.09.003     Document Type: Editorial

References (18)

1. A.S. Lok, and B.J. McMahon Chronic hepatitis B: update 2009 Hepatology 50 2009 661 662
2. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009;50:227-242.
3. Chotiyaputta W, Peterson C, Ditah FA, Goodwin D, Lok ASF. Persistance and adherence to nucleos(t)ide treatment for chronic hepatitis B. J Hepatol; in press.
4. L. Osterberg, and T. Blaschke Adherence to medication N Engl J Med 353 2005 487 497
5. World Health Organization. Adherence to long-term therapies: evidence for action. http://www.who.int/chp/knowledge/publications/adherence-full-report. pdf. Geneva: World Health Organization; 2003.
6. F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, and T.G. Cole The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1996 1001 1009
7. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-1357.
8. C.A. Jackevicius, M. Mamdani, and J.V. Tu Adherence with statin therapy in elderly patients with and without acute coronary syndromes JAMA 288 2002 462 467
9. J. Cramer, R. Rosenheck, G. Kirk, W. Krol, and J. Krystal Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes Value Health 6 2003 566 573
10. R.B. Haynes, H.P. McDonald, and A.X. Garg Helping patients follow prescribed treatment: clinical applications JAMA 288 2002 2880 2883
11. K. Schroeder, T. Fahey, and S. Ebrahim How can we improve adherence to blood pressure lowering medication in ambulatory care? Systematic review of randomized controlled trials Arch Intern Med 164 2004 722 732
12. T.J. Bramley, P.P. Gerbino, B.S. Nightengale, and F. Frech-Tamas Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations J Manag Care Pharm 12 2006 239 245
13. V. Fung, J. Huang, R. Brand, J.P. Newhouse, and J. Hsu Hypertension treatment in a medicare. A population: adherence and systolic blood pressure control Clin Ther 29 2007 972 984
14. A.J. Claxton, J. Cramer, and C. Pierce A systematic review of the associations between dose regimens and medication compliance Clin Ther 23 2001 1296 1310
15. T.R. Glass, S. De Geest, R. Weber, P.L. Vernazza, M. Rickenbach, and H. Furrer Correlates of self-reported nonadherence to anitretroviral therapy in HIV-infected patients: the Swiss HIV cohort study J Acquir Immune Defic Syndr 41 2006 L385 L392
16. M.M. Kitahata, S.D. Reed, P.W. Dillingham, S.E. Van Rompaey, A.A. Young, and R.D. Harrington Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death Int J STD AIDS 15 2004 803 810
17. J. Cramer Identifying and improving compliance patterns J.A. Cramer, B. Spilker, Patient compliance in medical practice and clinical trials 1991 Raven Press New York 387 392
18. Hongthanakorn C, Chotiyaputta W, Oberhelman K, Fontana RJ, Marrero JA, Licari TL, et al. Discrepancy between virological breakthrough and confirmed genotypic resistance in chronic hepatitis B patients receiving nucleos(t)ide analogue therapy in clinical practice. Gastroenterology 2010;138:S-793 [abstract].